Avidity Biosciences (RNA) PT Raised to $45 at BofA Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
Form 144 Avidity Biosciences, Filed by: LEVIN ARTHUR A
June 12, 2024 4:23 PM EDThtml,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td { margin: 0; padding: 0; border: 0; outline: 0; font-weight: inherit; font-style: inherit; font-size: 100%; font-family: inherit; vertical-align: baseline; } :focus { outline: 0; } body { line-height: 1; color: black; background: white; } .fakeBox { border-top: 1px solid #999; border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; border-left: 2px solid #999; padding: 0px; min-width: 300px;... More
Form 144 Avidity Biosciences, Filed by: MacLean Michael F
June 12, 2024 4:23 PM EDThtml,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td { margin: 0; padding: 0; border: 0; outline: 0; font-weight: inherit; font-style: inherit; font-size: 100%; font-family: inherit; vertical-align: baseline; } :focus { outline: 0; } body { line-height: 1; color: black; background: white; } .fakeBox { border-top: 1px solid #999; border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; border-left: 2px solid #999; padding: 0px; min-width: 300px;... More
Form 144 Avidity Biosciences, Filed by: Boyce Sarah
June 12, 2024 4:23 PM EDThtml,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td { margin: 0; padding: 0; border: 0; outline: 0; font-weight: inherit; font-style: inherit; font-size: 100%; font-family: inherit; vertical-align: baseline; } :focus { outline: 0; } body { line-height: 1; color: black; background: white; } .fakeBox { border-top: 1px solid #999; border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; border-left: 2px solid #999; padding: 0px; min-width: 300px;... More
Form 424B5 Avidity Biosciences,
June 12, 2024 4:19 PM EDTTable of Contents
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-279264
The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has been declared effective by the Securities and Exchange Commission. This preliminary prospectus supplement and the... More
